TransMedics (TMDX) Total Liabilities (2018 - 2026)

TransMedics has reported Total Liabilities for 9 years, with the latest figure at $940.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 64.7% year-over-year to $940.8 million; the trailing twelve-month figure through Mar 2026 stood at $940.8 million (up 64.7% YoY), and the FY2025 full-year result was $595.3 million, up 3.44% from the prior year.
• Total Liabilities for Q1 2026 stood at $940.8 million, up from $595.3 million in the prior quarter.
• The five-year high for Total Liabilities was $940.8 million in Q1 2026, with the low at $64.1 million in Q1 2022.
• Average Total Liabilities over 5 years is $449.0 million, with a median of $568.7 million recorded in 2024.
• Year-over-year, Total Liabilities surged 721.42% in 2023 and gained 0.66% in 2025.
• Tracing TMDX's Total Liabilities over 5 years: stood at $89.8 million in 2022, then jumped by 533.66% to $568.8 million in 2023, then increased by 1.17% to $575.5 million in 2024, then increased by 3.44% to $595.3 million in 2025, then surged by 58.05% to $940.8 million in 2026.
• The last three Total Liabilities figures came in at $940.8 million (Q1 2026), $595.3 million (Q4 2025), and $590.8 million (Q3 2025), per Business Quant data.

Peer Comparison